238 related articles for article (PubMed ID: 30930425)
1. Ginsenoside Rg3 Combined with Oxaliplatin Inhibits the Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells via Downregulating PCNA and Cyclin D1.
Shan K; Wang Y; Hua H; Qin S; Yang A; Shao J
Biol Pharm Bull; 2019 Jun; 42(6):900-905. PubMed ID: 30930425
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Lu M; Fei Z; Zhang G
Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway.
Jiang JW; Chen XM; Chen XH; Zheng SS
World J Gastroenterol; 2011 Aug; 17(31):3605-13. PubMed ID: 21987607
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.
Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H
Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594
[TBL] [Abstract][Full Text] [Related]
6. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
Xu P; Zhang X; Ni W; Fan H; Xu J; Chen Y; Zhu J; Gu X; Yang L; Ni R; Chen B; Shi W
Dig Dis Sci; 2015 Nov; 60(11):3351-63. PubMed ID: 26123838
[TBL] [Abstract][Full Text] [Related]
7. Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma.
Wang B; Xu Q; Zhou C; Lin Y
Acta Biochim Pol; 2021 Nov; 68(4):711-715. PubMed ID: 34730903
[TBL] [Abstract][Full Text] [Related]
8. M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma.
Guo B; Li L; Guo J; Liu A; Wu J; Wang H; Shi J; Pang D; Cao Q
Oncotarget; 2017 Jul; 8(27):44465-44476. PubMed ID: 28591705
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
[TBL] [Abstract][Full Text] [Related]
10. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
12. [Anticarcinogenic effect of 20(R)-ginsenoside Rg3 on induced hepatocellular carcinoma in rats].
Li X; Guan YS; Zhou XP; Sun L; Liu Y; He Q; Fu L; Mao YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):217-20. PubMed ID: 15807271
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
[TBL] [Abstract][Full Text] [Related]
16. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
Hong M; Almutairi MM; Li S; Li J
Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1].
Jian J; Hu ZF; Huang Y
Ai Zheng; 2009 May; 28(5):461-5. PubMed ID: 19624871
[TBL] [Abstract][Full Text] [Related]
18. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
